Venus Medtech Hangzhou Inc
HKEX:2500
Venus Medtech Hangzhou Inc
HKEX:2500
Price:
2.23
HKD
0.45%
Market Closed
Market Cap:
HK$983.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Venus Medtech Hangzhou Inc
HKEX:2500
|
CN |
|
Asuransi Bintang Tbk PT
IDX:ASBI
|
ID |
|
Mitsubishi UFJ Financial Group Inc
TSE:8306
|
JP |
|
S
|
SK Discovery Co Ltd
KRX:006120
|
KR |
|
Fulcrum Utility Services Ltd
LSE:FCRM
|
UK |
|
S
|
Shenzhen Desay Battery Technology Co Ltd
SZSE:000049
|
CN |
|
S
|
Solteq Oyj
OMXH:SOLTEQ
|
FI |
|
L
|
Lopez Holdings Corp
XPHS:LPZ
|
PH |
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
US |
Income Statement
Earnings Waterfall
Venus Medtech Hangzhou Inc
Venus Medtech Hangzhou Inc
Income Statement
Venus Medtech Hangzhou Inc
Venus Medtech Hangzhou Inc
Currency: CNY
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Interest Expense |
2
|
0
|
45
|
0
|
63
|
0
|
17
|
0
|
0
|
|
| Revenue |
416
N/A
|
387
-7%
|
406
+5%
|
452
+11%
|
491
+9%
|
466
-5%
|
471
+1%
|
427
-9%
|
307
-28%
|
|
| Gross Profit | ||||||||||
| Cost of Revenue |
(92)
|
(86)
|
(92)
|
(101)
|
(102)
|
(97)
|
(103)
|
(103)
|
(95)
|
|
| Gross Profit |
324
N/A
|
300
-7%
|
314
+5%
|
351
+12%
|
389
+11%
|
370
-5%
|
368
-1%
|
324
-12%
|
212
-35%
|
|
| Operating Income | ||||||||||
| Operating Expenses |
(745)
|
(768)
|
(1 506)
|
(1 568)
|
(1 107)
|
(901)
|
(1 103)
|
(970)
|
(597)
|
|
| Selling, General & Administrative |
(345)
|
(383)
|
(453)
|
(520)
|
(452)
|
(413)
|
(413)
|
(360)
|
(291)
|
|
| Research & Development |
(258)
|
(331)
|
(453)
|
(535)
|
(447)
|
(339)
|
(257)
|
(191)
|
(196)
|
|
| Depreciation & Amortization |
0
|
(43)
|
(75)
|
(67)
|
(78)
|
(72)
|
(85)
|
(90)
|
(71)
|
|
| Other Operating Expenses |
(142)
|
(11)
|
(526)
|
(446)
|
(130)
|
(76)
|
(349)
|
(329)
|
(39)
|
|
| Operating Income |
(420)
N/A
|
(468)
-11%
|
(1 192)
-155%
|
(1 217)
-2%
|
(718)
+41%
|
(531)
+26%
|
(735)
-38%
|
(646)
+12%
|
(385)
+40%
|
|
| Pre-Tax Income | ||||||||||
| Interest Income Expense |
46
|
(39)
|
58
|
(64)
|
(17)
|
(47)
|
(10)
|
(20)
|
(20)
|
|
| Non-Reccuring Items |
(3)
|
0
|
(22)
|
0
|
0
|
0
|
4
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(378)
N/A
|
(507)
-34%
|
(1 156)
-128%
|
(1 280)
-11%
|
(735)
+43%
|
(579)
+21%
|
(741)
-28%
|
(666)
+10%
|
(405)
+39%
|
|
| Net Income | ||||||||||
| Tax Provision |
6
|
13
|
34
|
32
|
6
|
7
|
23
|
22
|
(3)
|
|
| Income from Continuing Operations |
(371)
|
(494)
|
(1 122)
|
(1 249)
|
(729)
|
(572)
|
(717)
|
(643)
|
(408)
|
|
| Income to Minority Interest |
(2)
|
33
|
64
|
41
|
25
|
12
|
3
|
1
|
0
|
|
| Net Income (Common) |
(374)
N/A
|
(461)
-23%
|
(1 058)
-130%
|
(1 208)
-14%
|
(704)
+42%
|
(560)
+20%
|
(714)
-28%
|
(643)
+10%
|
(408)
+37%
|
|
| EPS (Diluted) |
-0.85
N/A
|
-1.05
-24%
|
-2.42
-130%
|
-2.75
-14%
|
-1.61
+41%
|
-1.28
+20%
|
-1.63
-27%
|
-1.47
+10%
|
-0.93
+37%
|
|
Switch to:
Switch to:
See Also
Discover More
